FindTrial
Sign In

A single arm, single-center study of the efficacy and safety in uterine sparing surgery for stage I placental site trophoblastic tumor (PinkRing study)

A single arm, single-center study of the efficacy and safety in uterine sparing surgery for stage I placental site trophoblastic tumor (PinkRing study)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099044
Enrollment
Unknown
Registered
2025-03-18
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placental Site Trophoblastic Tumor

Interventions

Surgical group:Lesion resection

Sponsors

The Obstetrics & Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Subject is able to sign an informed consent form, understand and agree to comply with the requirements and experimental procedures of the study; 2. Female subject aged >= 18 at the time of signing the informed consent form; 3. Pathological biopsy identifie as PSTT.

Exclusion criteria

Exclusion criteria: 1. Extrauterine metastasis confirmed by imaging diagnosis or pathology; 2. Poor general condition and inability to tolerate surgery. 3. Have an active infection or unexplained fever. 4. Organic or functional damage to important organs. 5. Patients with other cancers or other diseases that seriously affect the prognosis need to be excluded. 6. The lesion is diffuse and cannot be completely removed.

Design outcomes

Primary

MeasureTime frame
Remission rate;—

Countries

China

Contacts

Public ContactJinjuan Chen

The Obstetrics & Gynecology Hospital of Fudan University

oysterwithgrits@163.com+86 152 0181 4571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026